Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Hepatology
Reference11 articles.
1. Sun, Q. et al. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial H. pylori eradication. Helicobacter 15, 233–238 (2010).
2. Mu, F., Hu, F., Yang, G. & Cheng, H. A clinical study of proton pump inhibitor-containing quadruple regimen as first-line therapy for H. pylori eradication. Chin. J. Gastroenterol. 12, 531–534 (2007).
3. Zheng, Q., Pan, Y., Zhang, L. & Xiao, S. Comparison of efficacy of 7-day rabeprazole-based triple therapy versus quadruple therapy for treatment of H. pylori infection. Chin. J. Gastroenterol. 11, 645–647 (2006).
4. Calvet, X., Gené, E., López, T. & Gisbert, J. P. What is the optimal length of proton pump inhibitor-based triple therapies for H. pylori? A cost-effectiveness analysis. Aliment. Pharmacol. Ther. 15, 1067–1076 (2001).
5. Fuccio, L. et al. Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for H. pylori eradication. Ann. Intern. Med. 147, 553–562 (2007).
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献